Synthon ’s generic version of Copaxone at 40mg receives European approval to treat MS

Netherlands-based pharmaceutical company Synthon ’s 40mg/ml of glatiramer acetate has received regulatory approval for the treatment of relapsing forms of multiple sclerosis (MS) in Europe.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news